U.S. Injectable Drug Pipeline

Publication Date	June 2009
Publisher	Frost & Sullivan
Product Type	Report
Pages	128
ISBN Number	not applicable
Product Code	FRS01095

Buy this product or for assistance call +44 20 7060 7474

PDF £3,605.00$5997 | €4035

FAX Order above formats by FAX

Summary

This Frost & Sullivan research service titled U.S. Injectable Drug Pipeline provides an assessment of injectable drugs in clinical development in the United States, including pipeline lists by phase, commentary on selected products, and an analysis of the leading areas of pipeline compound distribution. It also provides insights and analysis of the key trends in the area, including main market drivers, market restraints, hot topics, and developments. Additionally, perception feedback from oncologists and cancer patients for intravenous injection, subcutaneous injection, and intramuscular injection, as well as feedback from cancer patients on their willingness to use pre-filled syringes and auto injectors, is provided. In this research, Frost & Sullivan's expert analysts thoroughly examine the following application segments: pharmaceuticals, biotechnology, oncology, biopharmaceuticals, and diabetes. The following technologies are covered in this research: subcutaneous injectable drugs, intramuscular injectable drugs, intravenous injectable drugs, and other injectable drugs.

This analysis is available through our Pharmaceuticals & Biotechnology Growth Partnership Services program. With continuous access to intelligence and resources from all seven perspectives of the Complex Business Universe, the Growth Partnership Services program ensures that you and your Growth Team??? are able to maintain a 360 Degree Perspective of the market. This comprehensive, objective information allows your company to mitigate risk, identify new opportunities, and drive effective strategies for growth. For more information on this custom subscription service, please click here.

Application Sectors

Expert Frost & Sullivan analysts thoroughly examine the following application sectors in this research:

Pharmaceuticals
Biotechnology
Oncology
Biopharmaceuticals
Diabetes

Technologies

The following technologies are covered in this research:

Subcutaneous injectable drugs
Intramuscular injectable drugs
Intravenous injectable drugs
Other injectable drugs

Content

1 EXECUTIVE SUMMARY
- Executive Summary
  - 1. Introduction
2 MARKET OVERVIEW
- Research Scope and Methodology
  - 1. Scope and Segmentation
  - 2. Research Methodology
- Market Introduction
  - 1. Introduction
  - 2. Hot Topics and Trends
  - 3. Patient Willingness to Use Injection Types
  - 4. Leading Companies
  - 5. Industry Challenges
  - 6. Market Drivers
  - 7. Market Restraints
3 PIPELINE ANALYSIS
- Introduction
  - 1. Pipeline Overview
- Intramuscular Injectable Drugs
  - 1. Introduction
  - 2. Phase III
  - 3. Phase II/III
  - 4. Phase II
  - 5. Phase I/II
  - 6. Phase I
- Subcutaneous Injectable Drugs
  - 1. Introduction
  - 2. Phase III
  - 3. Phase II/III
  - 4. Phase II
  - 5. Phase I/II
  - 6. Phase I
- Intravenous Injectable Drugs
  - 1. Introduction
  - 2. Phase III
  - 3. Phase II/III
  - 4. Phase II
  - 5. Phase I/II
  - 6. Phase I
- Other Injectable Drugs
  - 1. Introduction
  - 2. Phase III
  - 3. Phase II/III
  - 4. Phase II
  - 5. Phase I/II
  - 6. Phase I
4 DECISION SUPPORT DATABASES
- Oncology Databases
  - 1. Incidence of Colon Rectum Cancer
  - 2. Total Cancer Cases
  - 3. Incidence of Bladder Cancer
  - 4. Incidence of Breast Cancer
  - 5. Incidence of Lung Cancer
  - 6. Incidence of Stomach Cancer
- Autoimmune and Inflammatory Disorders Databases
  - 1. Prevalence of Asthma
  - 2. Prevalence of Arthritis
  - 3. Total Cases of Multiple Sclerosis
  - 4. Prevalence of Psoriasis
- Cardiovascular Disorders Databases
  - 1. Prevalence of Cardiovascular Diseases
  - 2. Prevalence of Coronary Heart Disease
List of Figures
- Injectable Drug Pipeline: Impact of Top Industry Challenges (U.S.), 2009-2015
- Injectable Drug Pipeline: Market Drivers Ranked in Order of Impact (U.S.), 2009-2015
- Injectable Drug Pipeline: Market Restraints Ranked in Order of Impact (U.S.), 2009-2015
- Injectable Drug Pipeline: Number of Injectable Compounds in Pipeline by Phase (U.S.), 2009
- Injectable Drug Pipeline: Number of Injectable Compounds in Pipeline by Classification (U.S.), 2009
- Injectable Drug Pipeline: Number of Injectable Compounds in Pipeline by Delivery Route (U.S.), 2009
- Injectable Drug Pipeline: Intramuscular Injectable Drugs Phase III Pipeline Analysis (U.S.), 2009
- Injectable Drug Pipeline: Intramuscular Injectable Drugs Phase II/III Pipeline Analysis (U.S.), 2009
- Injectable Drug Pipeline: Intramuscular Injectable Drugs Phase II Pipeline Analysis (U.S.), 2009
- Injectable Drug Pipeline: Intramuscular Injectable Drugs Phase I/II Pipeline Analysis (U.S.), 2009
- Injectable Drug Pipeline: Intramuscular Injectable Drug Phase I Pipeline Analysis (U.S.), 2009
- Injectable Drug Pipeline: Subcutaneous Injectable Drugs Phase III Pipeline Analysis (U.S.), 2009
- Injectable Drug Pipeline: Subcutaneous Injectable Drugs Phase II/III Pipeline Analysis (U.S.), 2009
- Injectable Drug Pipeline: Subcutaneous Injectable Drugs Phase II Pipeline Analysis (U.S.), 2009
- Injectable Drug Pipeline: Subcutaneous Injectable Drugs Phase I/II Pipeline Analysis (U.S.), 2009
- Injectable Drug Pipeline: Subcutaneous Injectable Drug Phase I Pipeline Analysis (U.S.), 2009
- Injectable Drug Pipeline: Intravenous Injectable Drugs Phase III Pipeline Analysis (U.S.), 2009
- Injectable Drug Pipeline: Intravenous Injectable Drugs Phase II/III Pipeline Analysis (U.S.), 2009
- Injectable Drug Pipeline: Intravenous Injectable Drugs Phase II Pipeline Analysis (U.S.), 2009
- Injectable Drug Pipeline: Intravenous Injectable Drugs Phase I/II Pipeline Analysis (U.S.), 2009
- Injectable Drug Pipeline: Intravenous Injectable Drug Phase I Pipeline Analysis (U.S.), 2009
- Injectable Drug Pipeline: Other Injectable Drug Phase III Pipeline Analysis (U.S.), 2009
- Injectable Drug Pipeline: Other Injectable Drugs Phase II/III Pipeline Analysis (U.S.), 2009
- Injectable Drug Pipeline: Other Injectable Drugs Phase II Pipeline Analysis (U.S.), 2009
- Injectable Drug Pipeline: Other Injectable Drugs Phase I/II Pipeline Analysis (U.S.), 2009
- Injectable Drug Pipeline: Other Injectable Drug Phase I Pipeline Analysis (U.S.), 2009
- Decision Support Database: Colon Rectum Cancer Incidence in '000 (World), 2002-2012
- Decision Support Database: Cancer Cases in '000 (World), 2002-2012
- Decision Support Database: Bladder Cancer Incidence in '000 (World), 2002-2012
- Decision Support Database: Breast Cancer Incidence in '000 (World), 2002-2012
- Decision Support Database: Lung Cancer Incidence in '000 (World), 2002-2012
- Decision Support Database: Stomach Cancer Incidence in '000 (World), 2002-2012
- Decision Support Database: Prevalence of Asthma in Million (World), 2002-2012
- Decision Support Database: Arthritis Prevalence in Million (World), 2002-2012
- Decision Support Database: Total Cases of Multiple Sclerosis in '000 (World), 2002-2012
- Decision Support Database: Population with Psoriasis in Million (US), 2002-2012
- Decision Support Database: Prevalence of Cardiovascular Diseases in Million (World), 2002-2012
- Decision Support Database: Coronary Heart Disease in '000 (World), 2002-2012